Literature DB >> 26635345

Prognostic Value of Myocardial Perfusion SPECT After Intravenous Bolus Administration of Nicorandil in Patients with Acute Ischemic Heart Failure.

Yoshimitsu Fukushima1, Shin-ichiro Kumita2, Yukichi Tokita3, Naoki Sato3.   

Abstract

UNLABELLED: Nicorandil, a hybrid adenosine triphosphate (ATP)-sensitive potassium channel opener and nitrate, is commonly used for the management of acute ischemic heart failure (AIHF). The aims of this study were to predict the effect of nicorandil by calculating myocardium-to-background ratio increasing rate (MBR-IR) using nicorandil stress myocardial perfusion SPECT and to evaluate the prognostic value of MBR-IR in patients with AIHF.
METHODS: Twenty-two patients (age, 70 ± 12 y) admitted to the coronary care unit with AIHF underwent nicorandil-stress and rest myocardial perfusion SPECT. Using these images, MBR-IR was calculated by dividing stress MBR by rest MBR (MBR = peak value of left ventricular myocardial segments/mean value of upper mediastinum). In order to evaluate the clinical importance of MBR-IR derived from the nicorandil-stress test, all patients were divided into 2 groups, based on the value of MBR-IR. All patients were observed over 5 y from the onset of AIHF for the occurrence of major adverse cardiac events (MACE).
RESULTS: Both high- and low-MBR-IR groups contained 11 participants. Median MBR-IR was 1.55 (1.34-1.61) in the high-MBR-IR group and 1.08 (1.02-1.10) in the low-MBR-IR group. The proportion of patients who experienced MACE was significantly higher in the low-MBR-IR group than in the high-MBR-IR group (91% vs. 18%, P < 0.001).
CONCLUSION: This study demonstrated that the MBR-IR calculated using nicorandil-stress myocardial perfusion SPECT may have a high prognostic value for MACE in patients with AIHF.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  acute ischemic heart failure; major adverse cardiac event; myocardium-to-background ratio increasing rate; nicorandil-stress myocardial perfusion imaging; single photon emission computed tomography

Mesh:

Substances:

Year:  2015        PMID: 26635345     DOI: 10.2967/jnumed.115.162420

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Clinical Effect of Nicorandil Combined with Aspirin in the Treatment of Myocardial Ischemia.

Authors:  Yue Li; Chen Zhao; Chengxin Xiong; Yuping Gao
Journal:  Biomed Res Int       Date:  2022-05-18       Impact factor: 3.246

2.  Feasibility of myocardial flow reserve prediction without the use of dynamic data from myocardial perfusion positron emission tomography.

Authors:  Hidenobu Hashimoto; Yoshimitsu Fukushima; Shin-Ichiro Kumita; Takeshi Tomiyama; Tomonari Kiriyama
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

3.  Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.

Authors:  Shu-Fang Pi; Ying-Wu Liu; Tong Li; Yu Wang; Quan Zhou; Bo-Jiang Liu; Wen-Jin Peng; Xin Li; Yun-Yun Wang; Lei Huang
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

4.  Cardiovascular magnetic resonance image analysis and mechanism study for the changes after treatments for primary microvascular angina pectoris.

Authors:  Qi Huang; Wen Ting Wang; Shi Sheng Wang; De An Pei; Xiang Qian Sui
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.